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ABSTRACT
Objective: Plants have been one of the important sources of medicines since the beginning of human civilization. Achyranthes aspera Linn. belonging 
to family Amaranthaceae, commonly found in India. The plant is used as antiarthritic, purgative, diuretic, antimalarial, etc.
Methods: The antihyperlipidemic activity of alcoholic and aqueous extracts of leaves of A. aspera was evaluated using triton-induced hyperlipidemia 
model in albino Wistar rats. The acute toxicity study confirmed that both the extracts were found to be safe at 5000 mg/kg b.w. in female albino 
Wistar rats. In this model, eight groups (six animals per group) of animals were used. Group I and II were considered as saline and hyperlipidemic 
controls, respectively, and other groups received their respective agents (alcoholic or aqueous extract/atorvastatin/ayurvedic preparation) and all the 
groups received triton WR1339 (200 mg/kg b.w. i.v.) except saline control group. Serum cholesterol and triglycerides (TGs) level are estimated for the 
evaluation of antihyperlipidemic effects of extracts.
Results: The ethanolic extract has shown a significant reduction in serum cholesterol and TGs level indicating antihyperlipidemic potentials in the 
plant while aqueous extract has not shown any beneficial effect.
Conclusion: In this triton-induced hyperlipidemia model, serum and TG levels were analyzed ethanolic extract was shown antihyperlipidemic activity. 
Further clinical studies are compulsory to confirm the findings.
Keywords: Achyranthes aspera, High-density lipoprotein, Low-density lipoprotein, Triglyceride, Total cholesterol, Triton, Antihyperlipidemic.
INTRODUCTION
Ancient medicinal herbal knowledge is trusted for its well-known 
uses in the prevention, diagnosis, treatment, and cure of a variety of 
diseases. Herbs have a defined kind of potency through which they can 
stimulate the human body to protect itself against the diseases. These 
medicinal herbs serve as a great source of remedies in the treatment of 
human and animal diseases.
There exists a plethora of knowledge and information and benefits of 
herbal drugs in our ancient literature of Ayurveda and Unani medicine. 
One of the earliest treatises of Indian medicine, the Charaka Samhita 
(1000 BC), mentions the use of over 2000 herbs for medicinal purpose. 
According to the WHO survey, 80% of the populations living in 
developing countries rely almost exclusively on traditional medicine for 
their primary health care needs.
Exploration of the chemical constituents of the plants and 
pharmacological screening may provide us the basis for developing the 
leads for development of novel agents [1].
This shows a need for planned activity guided phytopharmacological 
evaluation of herbal drugs. Achyranthes aspera Linn. is an annual, stiff 
erect herb, about 0.3-0.9 m height and found commonly as a weed 
throughout India. Atherosclerosis vascular disease is the leading cause 
of morbidity and mortality in the United States, accounting for more than 
one-third of all deaths each year. At any one time, 12 million Americans 
have coronary heart disease, 4 million have had strokes, and millions 
more have a significant claudication from peripheral arterial disease. 
Dyslipidemia is the most prevalent and important modifiable risk factor 
for atherosclerosis, affecting one in two (100 million) US adults [2].
A. aspera Linn. is used in indigenous system of medicine such as 
antibacterial, antiviral, anticancer, antioxidant, anti-inflammatory, and 
antiarthritic activity [3]. Hence, the present study is undertaken to 
evaluate the antihyperlipidemic activity of the ethanolic and aqueous 
extracts of the leaves of A. aspera at two different dose levels.
METHODS
List of chemicals used
•	 Cholesterol	(Burgoyne	Burbidges	and	Co.,	Mumbai)
•	 Coconut	oil	(Surya	Industries,	Udupi)
•	 Ayurvedic	preparation	 (Lean	Heal)	 (the	Arya	Vaidya	Pharmacy,	
Kerala)
•	 Lipid	profile	kit	for	cholesterol,	triglyceride	(TG),	and	high-density	
lipoprotein (HDL) (AGAPPE Diagnostic Ltd.)
•	 Atorvastatin	(Tonact-10,	Lupin	Pharmaceuticals,	Jammu).
Collection and authentication of plant material
The leaves of “A. aspera Linn.” were collected from local area in and around 
Mangalore,	in	the	month	of	June-July.	It	was	authenticated	by	Dr.	Noeline	J.	
Pinto,	HOD,	Department	of	Botany,	St.	Agnes	College,	Mangalore.	Thus,	
obtained leaves were cleaned from dust and other materials, and then, it 
was	dried	under	the	shade	for	15	days.	Moreover,	the	dried	leaves	were	
pulverized	in	an	electric	grinder	and	passed	through	Sieve	No.	40.	The	
powdered materials were subjected to maceration.
Preparation of extracts (ethanolic and aqueous)
The powder was soaked in 90% ethanol and distilled water separately 
for 6 days, stirring of the mixture was done thrice daily. The syrupy 
consistency materials obtained were concentrated by evaporating 
using the water bath until semisolid consistency was obtained. 
These ethanolic extracts (reddish-brown color) and aqueous extracts 
(dark greenish color) were having the weight about 35.5 and 101 g, 
respectively, and stored in a desiccator. The ethanolic extract was 
dissolved in water using tween 80 and the aqueous extract was freely 
soluble in the water.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Preliminary qualitative phytochemical analysis [4,5]
The ethanolic and aqueous extracts of leaves of A. aspera were subjected 
to qualitative examination for different phytoconstituents such as 
alkaloids, carbohydrates, flavonoids, glycosides, saponins, terpenoids, 



























Acute toxicity studies [6,7]
Acute toxicity study was conducted to determine the median lethal 
dose 50% (LD50) of the ethanolic and aqueous leaf extracts of the plant 
A. aspera. The acute toxicity study was carried out in adult female albino 
rats by “up and down” method and OECD guidelines 425. The limit 
test was used (the limit test is primarily used in situations where the 
experimenter has information indicating that the test material is likely 
to be nontoxic, i.e., having toxicity below regulatory limit doses).
The limit test is a sequential test that uses a maximum of five animals. 
A test dose of 2000 mg/kg, or exceptionally 5000 mg/kg, may be used. 
One animal dosed at the test dose. If the animal survived, four additional 
animals dosed sequentially so that a total of five animals were tested. 
In case three animals die, the limit test is terminated and main test is 
performed if LD50 is greater than the test dose, three or more animals 
will survive. However, all the dosed five animals were survived at 
2000 mg/kg. The alcoholic extract was dissolved in water using tween 
80 and prepared a concentration of 200 mg/ml and aqueous extract 
was dissolved in water and prepared a concentration of 500 mg/ml. 
The test dose is given to overnight fasted animals and continuously 
observed for 2-3 hrs for general behavioral, neurological, autonomic 
profiles then occasionally checked for the next 24 hrs and after 48 hrs 
(initial observation period). Further, animals were observed for 8 days 
(to check any late deaths). The limit test procedure of 5000 mg/kg was 
carried out according to OECD guidelines and found all the animals 
were well tolerated and survived. From this, one can conclude that the 
LD50 is more than 5000 mg/kg body weight.
Ethanolic and aqueous leaves extracts of the plant A. aspera dissolved in 
water using tween 80 and in water, respectively. The extracts were given 
initially to two separate animals and later to two different groups each 
group containing four animals (total five animals). There was no mortality 
and no signs of toxicity and the extracts were found to be safe at this dose 
level. The literature survey revealed that the LD50 is up to 8000 mg/kg [8].
All the experiments were performed within the guidelines of the 
Institutional	Animal	Ethics	Committee	of	K.S.	Hegde	Medical	Academy,	
Deralakatte,	Mangalore.	The	result	of	acute	toxicity	study	revealed	that	
the ethanolic and aqueous extracts of leaves of the plant A. aspera is safe 
at maximum dose of 5000 mg/kg body weight in rats.
Selection of animals
Rats are excellent subjects for toxicological studies (according to OECD 
guidelines). Wistar albino rats of either sex weighing between 150 and 
200	 g	 were	 obtained	 from	 NGSMIPS,	 Paneer,	 Deralakatte,	 Mangalore.	
These animals were used for the evaluation of antihyperlipidemic activity.
The animals were stabilized for 1 week; they were maintained in standard 
condition at room temperature; 60±5% relative humidity and 12 hrs light-
dark cycle. They had been given standard pellet diet supplied by Hindustan 
Lever	Co.,	Mumbai	and	water	ad libitum throughout the course of the study. 
The cleaning and sanitation work done alternative days and paddy husk 
was provided as bedding material, which was changed everyday. The cages 
and water bottles were regularly cleaned. The animals were handled gently 
to avoid giving them too much stress, which could result in an increased 
adrenal output. Institutional Animal Ethics Committee permission for the 
project	has	been	taken	(KSHEMA/AEC/072/2008).
Selection of doses
For the assessment of all the biological activities, two dose levels of 
ethanolic and aqueous extracts were chosen in such a way that higher 
dose was approximately one-tenth of the maximum dose concluded 
during the acute toxicity studies, and lower dose was 50% of the one-
tenth dose, i.e., 500 and 250 mg/kg body weight, respectively. The 
atorvastatin dose was taken 30 mg as normal human adult dose, which 
was 2.70 mg/kg b.w.as rat dose according to the conversion chart [5]. 
The ayurvedic preparation (Lean Heal) was calculated in accordance 
with volume to weight ratio, the dose specified on the label was one 
teaspoon as adult human dose, the weight of one teaspoon (4 ml) was 
5.20 g. This dose in rats was 468 mg/kg b.w. according to conversion 
chart [5]. The ayurvedic preparation (Lean Heal) is a polyherbal 
preparation	 having	 the	 coposition	 of	 Haritaki,	 Amalaki,	 Vibeethaki,	
Asanam, Draksha, Annabhedi Sinduram, and flavored syrup (q.s.).
Statistical analysis
The data were represented as mean±standard deviation (SD). The data 
of antihyperlipidemic activity of leaves of A. aspera were analyzed by 
one-way	analysis	of	 variance	 (ANOVA)	 followed	by	Dunnett’s	 test	 for	
comparison of data in between the groups. p<0.05 was considered as 
statistically significant.
Triton-induced hyperlipidemia [9,10]
Effect of aqueous and ethanolic extracts of leaves of A. aspera on 
triton-induced hyperlipidemia
Wistar albino rats of either sex weighing in between 150 and 250 g 
were divided into eight groups containing six animals in each group. 
After dividing the animals into different groups, they were kept in 
separate labeled cages. The rats were divided into the following groups:
•	 Group	I:	Served	as	control	(saline	only)
•	 Group	 II:	 Served	 as	 hyperlipidemic	 control	 -	 Received	 triton	
(200	mg/kg	b.w)	dissolved	in	0.15	M	NaCl
•	 Group	III:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15	M	NaCl	
+ ethanolic extract 250 mg/kg b.w.
•	 Group	IV:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15	M	NaCl	
+ ethanolic extract 500 mg/kg b.w.
•	 Group	V:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15M	NaCl	
+ aqueous extract 250 mg/kg b.w.
•	 Group	VI:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15M	NaCl	
+ aqueous extract 500 mg/kg b.w.
•	 Group	VII:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15M	NaCl	
+ ayurvedic preparation (Lean Heal) 468 mg/kg b.w. 
•	 Group	VIII:	Received	triton	(200	mg/kg	b.w)	dissolved	in	0.15M	NaCl	
+ atorvastatin 2.70 mg/kg b.w.
Procedure
The rats were fasted for 18 hrs and were injected through tail vein 
with 200 mg triton WR1339 (isooctyl-polyoxyethylene phenol)/kg 
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dissolved	in	0.15	M	NaCl.	The	saline	given	to	control	group,	 for	other	
groups respective extracts/atorvastatin/ayurvedic preparation were 
administered orally simultaneously with triton. The second dose 
was administered to the animals after 20 hrs, fasting was continued 
during the post triton period. The alcoholic and aqueous extracts were 
prepared as 100 mg/ml concentration for the oral dosing to the animals. 
The ayurvedic preparation (Lean Heal) had a free-flowing syrup-
like consistency, hence was easily dosed orally using the oral gavage. 
Atorvastatin was dissolved in water and orally dosed using the oral 
gavage. Blood was withdrawn using the heparinized capillaries from the 
retro-orbital sinus post triton administration, i.e., after 0 hr, 24 hrs, and 
48 hrs. The serum was obtained after centrifuging the blood, which was 
used to estimate the concentration of biochemical parameters using the 
semi autoanalyser and relevant lipid profile kits. Thus, obtained data 
are tabulated and checked for the statistical significance of the results 
using	 the	 statistical	 tools	 such	 as	 one-way	ANOVA.	 Finally,	 Dunnett’s	
test was applied to find out the difference between groups.
Analysis of serum biochemical parameters
•	 Quantitative	determination	of	TGs	(glycerol-3-phosphate	oxidase-	
peroxidase-antiperoxidase [PAP]-ESPAS methodology) [11-13]
•	 Quantitative	determination	of	 total	 cholesterol	 (TC)	 (cholesterol	
oxidase-PAP methodology) [14]





The ethanolic and aqueous extracts of leaves of A. aspera were found 
to be safe at the maximum dose of 5000 mg/kg body weight (p.o.). 
General behaviors, neurological, autonomic profiles were found to be 
normal.
Antihyperlipidemic activity
The evaluation of antihyperlipidemic activity of both ethanolic and 
aqueous extracts of leaves of A. aspera was carried out by successfully 
employing the triton-induced hyperlipidemia model. The serum 
cholesterol and TG levels were estimated in the triton-induced 
hyperlipidemic rats during synthesis and excretory phases of the 
experimental period. The results are tabulated.
Cholesterol
•	 Serum	cholesterol	levels	of	different	groups	of	animals	during	the	
study period are given in Table 1 and presented in Fig. 1. These 
observations were tabulated as mean (±SD), serum cholesterol levels 
of hyperlipidemic control rats were found to be 48.45±7.571 mg/dl 
at 0 hr, which was increased to 226.1±14.96 mg/dL at 24 hrs after 
triton administration (synthesis phase) and then was reduced to 
150.7±24.77 mg/dL after 48 hrs of triton administration (excretory 
phase).
•	 The	atorvastatin-treated	rats	showed	mean±SD	serum	cholesterol	
levels of 58.75±7.483 mg/dL at 0 hr, which was increased 
to 243.8±12.66 mg/dL after 24 hrs and was reduced to 
139.5±5.615 mg/dL after 48 hrs of triton administration, which 
was found to be similar to that of hyperlipidemic control group. 
This indicates that atorvastatin was not able to inhibit the rise of the 
serum cholesterol levels during synthesis phase of triton-induced 
hyperlipidemia model.
•	 The	 ethanolic	 extract	 (250	 and	 500	mg/kg)-treated	 rats	 had	
shown mean±SD serum cholesterol levels of 54.23±7.104 and 
50.00±11.97 mg/dL at 0 hr, which was increased to 196.5±21.73 
and 108.7±21.38 mg/dL after 24 hrs and reduced to 162.2±19.84 and 
90.13±17.14 mg/dL after 48 hrs of triton administration, respectively. 
This	was	 found	 to	be	significantly	 lower	 than	 the	hyperlipidemic	
control group. This indicates the dose-dependent action of extract on 
the serum cholesterol levels of the triton-induced hyperlipidemic rats.
Fig. 1: The serum cholesterol levels (mg/dl) in triton-induced hyperlipidemia. The values are represented as mean±standard deviation
Table 1: The effect of extracts on the serum cholesterol levels (mg/dl) in triton-induced hyperlipidemia
S.No. Group Serum cholesterol level (mg/dL) on day (Mean±SD)
0 hr 24 hrs 48 hrs
1 Saline control 48.37±7.446 52.88±5.856b** 49.38±7.548b**
2 Hyperlipidemic control 48.45±7.571 226.1±14.96a 150.7±24.77a
3 Ethanolic extract 250 54.23±7.104 196.5±21.73a,b* 162.2±19.84a,b
4 Ethanolic extract 500 50.00±11.97 108.7±21.38a,b** 90.13±17.14a,b**
5 Aqueous extract 250 51.40±7.702 259.4±18.19a# 173.4±6.773a,b#
6 Aqueous extract 500 46.78±4.679 198.6±13.24a,b* 139.7±9.728a
7 Ayurvedic preparation 53.83±5.067 284.1±14.27a,b# 143.6±9.904a
8 Atorvastatin (standard) 58.75±7.483 243.8±12.66a 139.5±5.615a
***p<0.001, **p<0.01, *p<0.05 (When compared with hyperlipidemic control), ap<0.05 (When compared with saline control), bp<0.05 (When compared with 
atorvastatin). #p<0.01 (significant high TC than hyperlipidemic group); n=6. TC: Total cholesterol, SD: Standard deviation
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•	 The	 aqueous	 extract	 (250	 and	 500	mg/kg)-treated	 rats	 had	
shown mean±SD serum cholesterol levels of 51.40±7.702 and 
46.78±4.679 mg/dL at 0 hr, which was increased to 259.4±18.19 and 
198.6±13.24 mg/dL after 24 hrs and reduced to 173.4±6.773 and 
139.7±9.728 mg/dL at 48 hrs after triton administration, respectively. 
This was found to be similar to that of hyperlipidemic control group. 
The aqueous extract (500 mg/kg)-treated rats had the serum 
cholesterol levels less than that of the hyperlipidemic control group 
after 24 hrs of triton injection. However, it was not able to control the 
serum	cholesterol	levels	significantly	lower	than	the	hyperlipidemic	




serum cholesterol levels of 53.83±5.067 mg/dL at 0 hr, which was 
increased to 284.1±14.27 mg/dL after 24 hrs and was reduced to 
143.6±9.904 mg/dL after 48 hrs of triton administration, which 
was found to be similar to that of hyperlipidemic control group. 
This indicates that ayurvedic preparation was not able to reduce the 
serum cholesterol levels in triton-induced hyperlipidemia model.
•	 The	normal	saline	control	rats	had	retained	the	serum	cholesterol	
levels uniformly during the experiment.
TG
•	 Serum	TG	levels	of	different	groups	of	animals	during	the	study	period	
are given in Table 2 and presented in Fig. 2. These observations were 
tabulated as mean±SD, serum TG levels of hyperlipidemic control rats 
were found to be 52.73±6.929 mg/dL at 0 hr, which was increased to 
389.8±19.43 mg/dL at 24 hrs after triton administration (synthesis 
phase) and then reduced to 176.1±10.43 mg/dL after 48 hrs of triton 
administration (excretory phase).
•	 The	 atorvastatin-treated	 rats	 showed	mean±SD	 serum	 TG	
levels of 56.77±10.64 mg/dL at 0 hr, which was increased 
to 371.7±23.35 mg/dL after 24 hrs and was reduced to 
190.3±18.24 mg/dL after 48 hrs of triton administration, which 
was found to be similar to that of hyperlipidemic control group. 
This indicates that atorvastatin was not able to inhibit the rise 
of the serum TG levels during synthesis phase of triton induced 
hyperlipidemic model.
•	 The	ethanolic	extract	(250	and	500	mg/kg)	treated	rats	had	shown	
mean±SD serum TG levels of 49.75±3.573 and 60.22±10.03 mg/dL 
at 0 hr, which was increased to 362.8±22.76 and 350.3±28.33 mg/dL 
after 24 hrs and reduced to 192.5±17.92 and 198.3±16.71 mg/dL at 
48 hrs after triton administration, respectively. The ethanolic extract 
at 250 mg/kg was not able to control the serum TG levels, but at 
the	dose	of	500	mg/kg,	it	was	able	to	show	a	significant	decrease	in	
serum TG levels in comparison with hyperlipidemic control group. 
This indicates that the ethanolic extract at a dose of 500 mg/kg was 
able	to	significantly	reduce	the	serum	TG	levels.
•	 The	aqueous	extract	(250	and	500	mg/kg)	treated	rats	had	shown	
mean±SD serum TG levels of 62.15±8.446 and 59.33±8.268 mg/dL 
at 0 hr, which was increased to 393.6±17.95 and 359.6±21.58 mg/dL 
after 24 hrs and reduced to 210.1±12.16 and 205.8±16.07 mg/dL at 
48 hrs after triton administration, respectively. This was found to be 
similar to that of hyperlipidemic control group. The aqueous extract 
(500 mg/kg)-treated rats had the serum TG levels less than that of 
the hyperlipidemic control group after 24 hrs of triton injection. 
However,	it	was	not	able	to	control	the	serum	TG	levels	significantly	
lower than the hyperlipidemic control group. This indicates that 
aqueous extract at the dose of 250 and 500 mg/kg was not able to 
significantly	reduce	the	serum	TG	levels.
•	 The	 ayurvedic	 preparation	 (Lean	Heal)	 treated	 rats	 showed	
mean±SD serum TG level of 49.62±6.755 mg/dL at 0 hr, which was 
increased to 340.1±21.07 mg/dL after 24 hrs and was reduced 
to 215.9±15.80 mg/dL after 48 hrs of triton administration. This 
was found to be lower serum TG levels than the hyperlipidemic 
control group. This indicates that ayurvedic preparation was able to 
reduce the serum TG level in triton-induced hyperlipidemia.
Fig. 2: The serum triglyceride levels (mg/dl) in triton-induced hyperlipidemia. The values are represented as mean±standard deviation
Table 2: Mean values of the serum TG levels (mg/dl) in triton-induced hyperlipidemia
S.No. Group Serum TG level (mg/dL) on day (Mean±SD)
0 hr 24 hrs 48 hrs
1. Saline control 58.92±8.152 65.10±11.17b** 59.62±7.530b**
2. Hyperlipidemic control 52.73±6.929 389.8±19.43a 176.1±10.43a
3. Ethanolic extract 250 49.75±3.573 362.8±22.76a 192.5±17.92a
4. Ethanolic extract 500 60.22±10.03 350.3±28.33a* 198.3±16.71a
5. Aqueous extract 250 62.15±8.446 393.6±17.95a 210.1±12.16a#
6. Aqueous extract 500 59.33±8.268 359.6±21.58a 205.8±16.07a#
7. Ayurvedic preparation 49.62±6.755 340.1±21.07a** 215.9±15.80a,b#
8. Atorvastatin (Standard) 56.77±10.64 371.7±23.35a 190.3±18.24a
***p<0.001, **p<0.01, *p<0.05 (when compared with hyperlipidemic control), ap<0.05 (when compared with saline control), bp<0.05 (when compared with 
atorvastatin), #p<0.01(significant high TC than hyperlipidemic group); n=6. TC: Total cholesterol, TG: Triglyceride
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•	 The	normal	 saline	control	 rats	had	retained	 the	serum	TG	 levels	
uniformly during the experiment.
DISCUSSION
Triton acts as a surfactant and suppresses the action of lipases to block 
the uptake of lipoproteins from circulation by extrahepatic tissues, 
resulting into increased blood lipid concentration [15]. The biphasic 
nature of triton-induced hyperlipidemia is helpful in understanding 
the mode of action of hypolipidemia agents. Drugs interfering with 
lipid biosynthesis or uptake will be active in the synthesis phase and 
metabolism will be active in the excretory phase. In the present study, 
the methanol extracts of three plants reduced the cholesterol and TGs 
in a manner similar to the reduction facilitated by atorvastatin.
The dried and powdered of A. aspera Linn. leaves was subjected to soxhlet 
extraction with 90% ethanol. The yield of the extract was 10% w/w. 
Phytochemical analysis of the ethanolic extract showed different 
phytoconstituents, namely, glycosides, phytosterols, triterpenoids, 
alkaloids, and flavonoids. Glycosides, triterpenoids, saponins, alkaloids, 
and flavonoids are known to have antihyperlipidemic property. It has 
been well established that nutrition plays an important role in the 
etiology of hyperlipidemia and atherosclerosis [16,17].
A. aspera has been shown to decrease the serum as well as liver levels 
of lipids and enhanced the excretion of bile acids. The alcoholic extract 
of A. aspera contains glycosides of oleanolic acid (saponin A and B) 
with steroidal nucleus. It has been reported that cardiac stimulant and 
diuretic activity of the saponins from this plant. The lipid-lowering 
activity of A. aspera may contribute to these pharmacological properties. 
Hypocholesterolemic effect of A. aspera may be in part due to its 
action on fecal excretion of bile acids which may regulate cholesterol 
homeostasis [18-20]. The detailed study is further required in clinical 
aspects and molecular level to prove the aqueous and ethanolic extract 
of A. aspera to reduce the cholesterol and TG levels. Furthermore, to 
prevent the cardiovascular and cerebrovascular diseases in clinical is 
needed.
CONCLUSION
The obesity epidemic in the India has led to a high-priority search 
for Indian herbal therapies that work effectively. Although there is no 
magic bullet available among Indian herbs that can melt the kilograms 
of fat in a short period, there is a need to create awareness regarding the 
evidence for and use of natural products in the form of raw materials, 
crude extracts, or isolated compounds to promote weight loss and thus 
control obesity [19].
The present study was conducted to evaluate the antihyperlipidemic 
activity of ethanolic and aqueous extracts of leaves of A. aspera by 
employing triton-induced hyperlipidemia model. The results were 
compared with atorvastatin. Ethanolic and aqueous extracts of leaves 
of A. aspera were found to be practically nontoxic and safe since it does 
not have any lethal effect even at a dose of 5000 mg/kg body weight 
when given orally to the adult female albino wistar rats.
In triton-induced hyperlipidemia model, triton produced a significant 
rise in serum TC and TG levels in hyperlipidemic control group. 
Ethanolic extract (500 mg/kg) produced a significant decrease in TC 
and TG levels. The present study shows that ethanolic extract of leaves 
of A. aspera found to have antihyperlipidemic activity on hyperlipidemic 
rats. However, it requires separation of the exact compound responsible 
for its antihyperlipidemic activity and further evaluation in different 
models and clinical studies is necessary to confirm the findings.
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